Jin-Fang Luo

614 total citations
21 papers, 492 citations indexed

About

Jin-Fang Luo is a scholar working on Molecular Biology, Pharmacology and Complementary and alternative medicine. According to data from OpenAlex, Jin-Fang Luo has authored 21 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Pharmacology and 5 papers in Complementary and alternative medicine. Recurrent topics in Jin-Fang Luo's work include Medicinal Plant Extracts Effects (5 papers), Natural product bioactivities and synthesis (5 papers) and Phytochemistry and Biological Activities (4 papers). Jin-Fang Luo is often cited by papers focused on Medicinal Plant Extracts Effects (5 papers), Natural product bioactivities and synthesis (5 papers) and Phytochemistry and Biological Activities (4 papers). Jin-Fang Luo collaborates with scholars based in China, Macao and Portugal. Jin-Fang Luo's co-authors include Hua Zhou, Jianxin Liu, Yun-Da Yao, Zhongqiu Liu, Ying Xie, Xiu‐Yu Shen, Yi Dai, Xin‐Sheng Yao, Yang Yu and Pei Luo and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Jin-Fang Luo

20 papers receiving 488 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jin-Fang Luo China 12 243 115 70 68 57 21 492
Yun-Da Yao China 11 204 0.8× 52 0.5× 75 1.1× 44 0.6× 42 0.7× 15 374
Jia‐Ying Wu Hong Kong 14 282 1.2× 62 0.5× 49 0.7× 58 0.9× 59 1.0× 33 512
Ke‐Gang Linghu China 17 300 1.2× 60 0.5× 56 0.8× 146 2.1× 57 1.0× 34 619
Guozhu Han China 13 294 1.2× 38 0.3× 52 0.7× 77 1.1× 57 1.0× 33 610
Yeer Liang Macao 12 351 1.4× 165 1.4× 39 0.6× 126 1.9× 51 0.9× 13 710
Qiqi Xin China 14 235 1.0× 81 0.7× 61 0.9× 86 1.3× 45 0.8× 36 609
Rajapaksha Gedara Prasad Tharanga Jayasooriya South Korea 15 359 1.5× 72 0.6× 81 1.2× 72 1.1× 83 1.5× 29 704
Bin‐Feng Cheng China 17 409 1.7× 92 0.8× 73 1.0× 180 2.6× 93 1.6× 47 792
Sun‐Oh Jeong South Korea 16 434 1.8× 100 0.9× 40 0.6× 38 0.6× 46 0.8× 18 785
Hong-Kun Rim South Korea 16 308 1.3× 83 0.7× 98 1.4× 71 1.0× 43 0.8× 30 649

Countries citing papers authored by Jin-Fang Luo

Since Specialization
Citations

This map shows the geographic impact of Jin-Fang Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jin-Fang Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jin-Fang Luo more than expected).

Fields of papers citing papers by Jin-Fang Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jin-Fang Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jin-Fang Luo. The network helps show where Jin-Fang Luo may publish in the future.

Co-authorship network of co-authors of Jin-Fang Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Jin-Fang Luo. A scholar is included among the top collaborators of Jin-Fang Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jin-Fang Luo. Jin-Fang Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Cui, et al.. (2025). Advances in Traditional Chinese Medicine for Modulating DNA Methylation in the Treatment of Inflammatory Diseases. International Journal of Molecular Sciences. 26(13). 6331–6331.
3.
Luo, Jin-Fang, Yang Yu, & Jianxin Liu. (2024). Mechanism of Asperosaponin VI Related to EGFR/MMP9/AKT/PI3K Pathway in Treatment of Rheumtoid Arthritis. Chinese Journal of Integrative Medicine. 31(2). 131–141. 3 indexed citations
5.
Yao, Yun-Da, Jin-Fang Luo, Jianxin Liu, et al.. (2023). Pharmacological mechanisms of sinomenine in anti-inflammatory immunity and osteoprotection in rheumatoid arthritis: A systematic review. Phytomedicine. 121. 155114–155114. 24 indexed citations
7.
Li, Jing, Lang Yi, Ruili Zhu, et al.. (2022). Sinomenine inhibits macrophage M1 polarization by downregulating α7nAChR via a feedback pathway of α7nAChR/ERK/Egr-1. Phytomedicine. 100. 154050–154050. 23 indexed citations
8.
Luo, Jin-Fang, Yun-Da Yao, Chunsong Cheng, et al.. (2022). Sinomenine increases the methylation level at specific GCG site in mPGES-1 promoter to facilitate its specific inhibitory effect on mPGES-1. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1865(3). 194813–194813. 7 indexed citations
9.
Luo, Jin-Fang, et al.. (2022). Akebia Saponin D Inhibits the Inflammatory Reaction by Inhibiting the IL-6-STAT3-DNMT3b Axis and Activating the Nrf2 Pathway. Molecules. 27(19). 6236–6236. 16 indexed citations
10.
Zhang, Yanyu, Yun-Da Yao, Jin-Fang Luo, et al.. (2021). Microsomal prostaglandin E2 synthase-1 and its inhibitors: Molecular mechanisms and therapeutic significance. Pharmacological Research. 175. 105977–105977. 28 indexed citations
11.
Luo, Jin-Fang, et al.. (2020). The Activity Screening of Hmong Herbs Caesalpiniaminax and an Antitumor Effect Study. Evidence-based Complementary and Alternative Medicine. 2020(1). 3585736–3585736. 1 indexed citations
12.
Luo, Jin-Fang, Xiu‐Yu Shen, Yi Dai, et al.. (2019). Nardosinanone N suppresses LPS-induced macrophage activation by modulating the Nrf2 pathway and mPGES-1. Biochemical Pharmacology. 173. 113639–113639. 13 indexed citations
13.
Yao, Yun-Da, Xiu‐Yu Shen, Jorge Machado, et al.. (2019). Nardochinoid B Inhibited the Activation of RAW264.7 Macrophages Stimulated by Lipopolysaccharide through Activating the Nrf2/HO-1 Pathway. Molecules. 24(13). 2482–2482. 23 indexed citations
14.
Zhu, Ruili, Lang Yi, Jin-Fang Luo, et al.. (2019). Sinomenine regulates CD14/TLR4, JAK2/STAT3 pathway and calcium signal via α7nAChR to inhibit inflammation in LPS-stimulated macrophages. Immunopharmacology and Immunotoxicology. 41(1). 172–177. 44 indexed citations
15.
Luo, Jin-Fang, Xiu‐Yu Shen, Yi Dai, et al.. (2018). Activation of Nrf2/HO-1 Pathway by Nardochinoid C Inhibits Inflammation and Oxidative Stress in Lipopolysaccharide-Stimulated Macrophages. Frontiers in Pharmacology. 9. 911–911. 150 indexed citations
16.
Zhou, Hua, Jianxin Liu, Jin-Fang Luo, et al.. (2017). Suppressing mPGES-1 expression by sinomenine ameliorates inflammation and arthritis. Biochemical Pharmacology. 142. 133–144. 55 indexed citations
18.
Shen, Xiu‐Yu, Yang Yu, Guo‐Dong Chen, et al.. (2017). Six new sesquiterpenoids from Nardostachys chinensis Batal. Fitoterapia. 119. 75–82. 11 indexed citations
19.
20.
Yi, Lang, Jin-Fang Luo, Bing Xie, et al.. (2015). α7 Nicotinic Acetylcholine Receptor is a Novel Mediator of Sinomenine Anti-Inflammation Effect in Macrophages Stimulated by Lipopolysaccharide. Shock. 44(2). 188–195. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026